Navigation Links
Pharmacokinetic Data Suggest NGX426, TorreyPines Therapeutics' Oral Prodrug of Tezampanel, May be Effective in Treating Acute Migraine Headache
Date:12/10/2007

t's expectations are described in greater detail in the TorreyPines Therapeutics annual report on Form 10-K for the year ended Dec. 31, 2006, as well as TorreyPines Therapeutics' subsequent filings with the Securities and Exchange Commission. TorreyPines Therapeutics undertakes no obligation to publicly release the result of any revisions to such forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Company Contact: Media Contact:

Ev Graham David Schull

TorreyPines Therapeutics, Inc. Russo Partners, LLC

858-623-5665, x118 212-845-4271

egraham@torreypinestherapeutics.com david.schull@russopartnersllc.com

Investor Contact: Investor Contact:

Rhonda Chiger John Baldissera

Rx Communications BPC Financial Marketing

917-322-2569 800-368-1217

rchiger@rxir.com


'/>"/>
SOURCE TorreyPines Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
2. PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy
3. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
4. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
5. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
6. Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
7. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
8. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Services, Inc. (NYSE: WST ) today announced ... the first-quarter 2010 cash dividend of $0.16 per share. ... to shareholders of record on January 20, 2010. ... global manufacturer of components and systems for injectable drug ... and disposable components used in syringe, IV and blood ...
(Date:12/15/2009)... Del., Dec. 15 The U.S. Food and ... (EMDAC) today voted 12 yes, 4 no, and 1 ... the observed risks to support the use of CRESTOR® ... Men greater than or equal to 50 years, ... Fasting LDL < 130 mg/dL; hsCRP greater than ...
(Date:12/15/2009)... SRI International, an independent nonprofit research and development ... 7,592,021 for a new bioadhesive drug delivery system ... human body,s mucous membranes. This needle-free option uses ... much longer release time compared to alternatives such ... an effective means to introduce drugs across the ...
Breaking Medicine Technology:Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 2Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 3Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 4Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 5SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5Are intravenous treatments safe 3F New research raises doubts 55731 1Are intravenous treatments safe 3F New research raises doubts 55731 2Open source DNA 55727 1New developments in reproductive medicine 9741 1New developments in reproductive medicine 9741 2
... Biotechnologies,announced today the results of Phase I/II and ... sarcoma and osteosarcoma, as,presented by Dr. Sant P. ... held in London UK on November 13-15, 2008. ... period up to 9 months. Analysis of,safety and ...
... PHILADELPHIA, Nov. 20 GlaxoSmithKline (NYSE: GSK ... and Drug Administration (FDA) granted accelerated approval for ... patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) ... immunoglobulins or splenectomy. The approval is a significant ...
Other Medicine Technology:Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8
(Date:12/16/2009)... In one-fourth the time it takes to obtain a bachelor ... an ophthalmic assistant. , ... (Vocus) ... : The National Report Card on Higher Education" by the ... college tuition have outpaced price increases in other sectors of ...
(Date:12/16/2009)... Shapio,s Help Hair Shake in all of the Florida Whole Foods store. ... ... Dr. Larry Shapiro, hair transplant and hair loss physician , ... the Help Hair Whey Protein Shake. Dr. Shapiro developed the all ... weight loss programs, working out and muscle building., , , , ,The ...
(Date:12/15/2009)... Authority, Ban on Annual Benefit Limits, & Effective ... -- Consumer Watchdog condemned the removal of the ... the public option from the U.S. Senate health ... Senate must still make three essential fixes to ... entire health care system to the insurance industry. ...
(Date:12/15/2009)... of America and the Saint Thomas, Lupus Trust ... son of the legendary John Lennon, and James Scott ... raise funds for research on the disease lupus. From ... proceeds from downloading "LUCY" at iTunes will be donated ... Saint Thomas, Lupus Trust in Great Britain. ,, Both ...
(Date:12/15/2009)... swine flu were worse, ,we would have really been ... News) -- The outbreak of the pandemic H1N1 swine ... to respond to public health emergencies, a new report ... America,s Health and the Robert Wood Johnson Foundation, also ... public health system. , "The 2009 H1N1 outbreak is ...
Breaking Medicine News(10 mins):Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 2Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 3Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 4Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 5Health News:Florida Whole Foods Stores to Carry Dr. Lawrence Shapiro's Help Hair Shake 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3
... March 19 Inverness Medical Innovations, Inc. (NYSE: ... to take charge of their health at home through ... today that it has entered into a definitive agreement ... ACON,s world-wide business of researching, developing, manufacturing, marketing and ...
... found to be less pronounced in highly social men ... might enhance the cardiovascular health benefits of light-to-moderate drinking, ... risk of stroke, but studies have linked light-to-moderate drinking ... heart disease. Other research has found that people with ...
... between Patients and PhysiciansALEXANDRIA, Va., March 19 Patients ... wishes with their physicians had significantly lower healthcare costs ... these conversations between patients and physicians led to fewer ... in a far more peaceful death for patients. ...
... movement could break down barriers and reduce over-treatment and ... physicians would like their patients to be better informed ... changes that would improve their health, and the surgery ... shared medical decision-making, whereby doctors and patients work together ...
... opinions prove better in predicting satisfaction with a choice, study finds ... a movie. What would better predict whether you,ll like the film: ... you know about the cast and plot? , Researchers say you,d ... trying to figure out whether to become a lawyer or vacation ...
... stories in health care, will be held at the Royal ... and will bring together leading doctors from many medical specialties. ... Network,s journals Richard Smith (the former editor of the ... Smith said of Cases Network,s goal, "Case reports are at ...
Other Medicine News:Health News:Inverness Medical Innovations Agrees to Acquire 'Second Territory' Rapid Diagnostics Business of ACON 2Health News:Inverness Medical Innovations Agrees to Acquire 'Second Territory' Rapid Diagnostics Business of ACON 3Health News:Inverness Medical Innovations Agrees to Acquire 'Second Territory' Rapid Diagnostics Business of ACON 4Health News:Support Network May Play Role in Benefits of Drinking 2Health News:Discussions About End-of-Life Care Reduce Healthcare Costs in Last Week of Life 2Health News:Physicians Favor Patient Involvement in Decision Making, But Cite Barriers Such as Time and Money 2Health News:Physicians Favor Patient Involvement in Decision Making, But Cite Barriers Such as Time and Money 3Health News:Trying to Decide? Forget the Facts and Phone a Friend 2
The Pan Retinal® 2.2 uniquely combines magnification nearly that of the 20D lens with a field of view approaching that of the 30D lens. Excellent for virtually every examination procedure, includ...
This excellent mid-power lens provides medium field and magnification, with an ideal diameter for grip andmanipulation in the orbital area....
... Macula Plus® 5.5 is ... of the optic nerve ... it with your binocular ... choroidal neovascular membranes, macular ...
The iQ200 Automated Urinalysis System (iQ System) is a user-friendly, bench top, fully automated system that performs complete urinalyses on unspun specimens; simply load, press START and walk away....
Medicine Products: